Engineering layered double hydroxide nanoparticles toward an efficient targeted clinical delivery system. This project will develop a more effective drug delivery system using clay nanoparticles and biofriendly serum proteins. Outcomes from this project will provide a tremendous opportunity for potent therapies of cancers, vasculature and neuronal diseases, and place Australia at the forefront of nanotechnology drug delivery research.
Discovery Early Career Researcher Award - Grant ID: DE210101666
Funder
Australian Research Council
Funding Amount
$395,588.00
Summary
Engineering nanoparticles with enhanced adhesion at the nano-bio interfaces. This project aims to develop a next-generation adhesive nanoparticle platform through in-depth understandings of nanoparticle interactions with bio-interfaces. This project expects to generate new knowledge in the multidisciplinary research field at nano-bio-interfaces by using a recently developed nano-colloidal probe technology, instructing the rational design of nanoparticles with enhanced interface adhesive properti ....Engineering nanoparticles with enhanced adhesion at the nano-bio interfaces. This project aims to develop a next-generation adhesive nanoparticle platform through in-depth understandings of nanoparticle interactions with bio-interfaces. This project expects to generate new knowledge in the multidisciplinary research field at nano-bio-interfaces by using a recently developed nano-colloidal probe technology, instructing the rational design of nanoparticles with enhanced interface adhesive properties. Expected outcomes include a family of adhesive nanoparticles designed for nanopesticide and animal feed applications, with the potential to deliver valuable intellectual property of commercial interest and economic benefit through technology advancement.Read moreRead less
Single molecule sensing on nanopillars: Reading complex molecular circuits. This project aims to develop an entirely new nanotechnology to visualise dynamic molecular circuits in real time, and within any biological sample as small as a single cell. This project expects to generate new knowledge in the field of cell biology and sensor technology, using innovative nanofabrication and nanoscopic fluid flows to advance understanding of the emerging field of single protein molecule interactions in c ....Single molecule sensing on nanopillars: Reading complex molecular circuits. This project aims to develop an entirely new nanotechnology to visualise dynamic molecular circuits in real time, and within any biological sample as small as a single cell. This project expects to generate new knowledge in the field of cell biology and sensor technology, using innovative nanofabrication and nanoscopic fluid flows to advance understanding of the emerging field of single protein molecule interactions in cellular pathways. Expected outcomes include a universal technology platform to detect single molecules in single cells, with potential to deliver valuable intellectual property of commercial interest and economic benefit through technological advancements.Read moreRead less
Next generation hybrid nanomaterials: bispecific antibody-targeted polymers. This project aims to develop and optimise a novel platform technology that will assist in the development of hybrid materials consisting of nanomaterials and biomolecules, which form the basis of many commercial diagnostic devices. A novel antibody, MIL38, will provide the test bed for the technology, which will aim to deliver a platform that is stable under physiological conditions and that enables facile conjugation o ....Next generation hybrid nanomaterials: bispecific antibody-targeted polymers. This project aims to develop and optimise a novel platform technology that will assist in the development of hybrid materials consisting of nanomaterials and biomolecules, which form the basis of many commercial diagnostic devices. A novel antibody, MIL38, will provide the test bed for the technology, which will aim to deliver a platform that is stable under physiological conditions and that enables facile conjugation of nanomaterials with antibodies. This project has the potential to rapidly improve the ligation process between synthetic nanomaterials and biologics, leading to more efficient synthesis of targeted diagnostics. This would provide a significant commercial advantage for any nanomaterials developed for the field, and specifically for this project, expedite translation of MIL38.Read moreRead less
Bespoke nanomaterials for understanding nano-bio interactions under flow. This project aims to develop innovative scalable synthesis techniques to produce polymeric nanomaterials with controlled properties and characterise interactions between nanomaterials and cells under flow conditions. This project expects to generate new knowledge in priority research areas of nanotechnology, polymer chemistry and immunology. The outcome of this project is an original scalable and environmentally friendly t ....Bespoke nanomaterials for understanding nano-bio interactions under flow. This project aims to develop innovative scalable synthesis techniques to produce polymeric nanomaterials with controlled properties and characterise interactions between nanomaterials and cells under flow conditions. This project expects to generate new knowledge in priority research areas of nanotechnology, polymer chemistry and immunology. The outcome of this project is an original scalable and environmentally friendly technology, new knowledge of cell-nanomaterial interactions and new design principles for nanoparticles with potential future applications in drug delivery, immunology and nanomedicine. This project should provide significant benefits to polymer, nanomaterial and pharmaceutical research and industry in Australia.Read moreRead less
Bioengineering self-assembly of innovative core-shell nanomaterials . This project aims to generate new knowledge in nanoscale bioengineering. It expects to develop a disruptive platform technology for design and manufacture of advanced nanomaterials to provide solutions for unmet needs in industry. It will explore an innovative bioengineering concept that merges biopolymer synthesis with virus-like particle self-assembly to produce innovative tunable core-shell nanomaterials. Expected outcomes ....Bioengineering self-assembly of innovative core-shell nanomaterials . This project aims to generate new knowledge in nanoscale bioengineering. It expects to develop a disruptive platform technology for design and manufacture of advanced nanomaterials to provide solutions for unmet needs in industry. It will explore an innovative bioengineering concept that merges biopolymer synthesis with virus-like particle self-assembly to produce innovative tunable core-shell nanomaterials. Expected outcomes are the development of advanced techniques for design and manufacture of innovate nanomaterials with enhanced stability and performance. This innovative platform technology for precision engineering of high-performance nanomaterials should provide significant benefits for biotechnological and agricultural industries.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE160100704
Funder
Australian Research Council
Funding Amount
$355,000.00
Summary
Development of Two-Dimensional MnO2 Nanosheets for a theranostic platform. This project aims to develop a novel diagnostic and therapeutic nanoplatform for cancer treatment that will improve cancer diagnosis and monitoring of treatment and reduce the side-effects of chemotherapy. The platform, based on biocompatible, ultrasmall and targeted two-dimensional manganese-oxide nanosheets, aims to combine simultaneous targeting, stimuli-responsive magnetic resonance imaging and drug release and delive ....Development of Two-Dimensional MnO2 Nanosheets for a theranostic platform. This project aims to develop a novel diagnostic and therapeutic nanoplatform for cancer treatment that will improve cancer diagnosis and monitoring of treatment and reduce the side-effects of chemotherapy. The platform, based on biocompatible, ultrasmall and targeted two-dimensional manganese-oxide nanosheets, aims to combine simultaneous targeting, stimuli-responsive magnetic resonance imaging and drug release and delivery. This should enable precise imaging of tumour tissues and enhanced drug delivery triggered by the physiological tumour microenvironment. The translation of this technology into clinical practice is likely to have significant benefits for the efficient treatment of cancer.Read moreRead less
Optimisation of functional mesoporous materials for low-abundance biomarkers quantification towards biodiagnostic applications. Using state-of-the-art nanotechnology, a novel approach will be developed to quantitatively analyse low abundance peptides and proteins. This will aid in the detection of a biomarker in osteoarthritis, a disease affecting 3.85 million Australians. This project has significance for the early diagnosis and improved treatment of this disease.
Designer Nanoparticles Enable mRNA Protein Factories. Intracellular delivery of mRNA facilitates target protein production, which could build protein factories that are essential in biomanufacturing industries. However, the instability of mRNA greatly lowers the protein production performance, limiting the commercial translation potential. This project aims to develop a new generation of nanoparticle delivery system to enhance mRNA stability against intracellular unstable cue, enzymatic digestio ....Designer Nanoparticles Enable mRNA Protein Factories. Intracellular delivery of mRNA facilitates target protein production, which could build protein factories that are essential in biomanufacturing industries. However, the instability of mRNA greatly lowers the protein production performance, limiting the commercial translation potential. This project aims to develop a new generation of nanoparticle delivery system to enhance mRNA stability against intracellular unstable cue, enzymatic digestion and thermal stress. This will be achieved by tailoring the nanochemistry at multi-scales. Expected outcomes include new knowledge in custom-design of functional nanomaterials for mRNA delivery, and new technology that will bring commercial benefits to the partner organisation and the biopharma sector.Read moreRead less